27 February 2008
Race and ethnicity coding agreement between hospitals and between hospital and death data
Kevin Fiscella, Sean MeldrumMed Sci Monit 2008; 14(3): SR9-13 :: ID: 836567
Abstract
Background
Little is known regarding the reliability of hospital coding for race and ethnicity particularly for Hispanics, Asians, and American Indians. We assessed these questions using hospital and mortality data from a large, diverse state.
Material and Method
We used California hospital discharge data 1998--2000 and linked death data. We assessed crude agreement and kappas for race and ethnicity coding between admissions to different hospitals and between hospital admissions and death data.
Results
Overall kappas for race and ethnicity were higher between hospital and death data than between different hospitals. Kappas between hospital admission and death certificate data differed by race and ethnicity. Reasonable kappas were observed for Blacks (0.92), Asians and Pacific Islanders (0.88), Hispanics (0.77), and Whites (0.76), but not for American Indians (0.27) or others (<0.01). Crude agreement for race and ethnicity varied for Asians and Hispanics based on country of origin. It was highest for persons born in China (93%) and Southeast Asian (93%) and Mexico (82%) and lowest for persons born in India (38%) and for "Other Spanish/Hispanics" born in (42%) and outside the US (46%).
Conclusions
Race and ethnicity coding agreement between hospitals and between hospitals and death certificate is generally good for most major and ethnic groups and subgroups with the notable exception of American Indians, persons of other races, and selected Asians and Hispanics born in certain countries.
Keywords: Medical Records - statistics & numerical data, Mortality - ethnology, Forms and Records Control - methods, Death Certificates, Ethnic Groups - statistics & numerical data, Cross-Sectional Studies, Continental Population Groups - statistics & numerical data
517 8
Editorial
01 May 2023 : Editorial
Editorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor TherapyDOI: 10.12659/MSM.940911
Med Sci Monit 2023; 29:e940911
In Press
31 May 2023 : Review article
Prevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.939919
30 May 2023 : Clinical Research
A Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...Med Sci Monit In Press; DOI: 10.12659/MSM.940409
30 May 2023 : Review article
A Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...Med Sci Monit In Press; DOI: 10.12659/MSM.940550
30 May 2023 : Database Analysis
The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952